File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.neuropharm.2022.109000
- WOS: WOS:000786647700002
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Article: Degraded cortical temporal processing in the valproic acid-induced rat model of autism
Title | Degraded cortical temporal processing in the valproic acid-induced rat model of autism |
---|---|
Authors | |
Issue Date | 2022 |
Citation | Neuropharmacology, 2022, v. 209, p. 109000 How to Cite? |
Abstract | Hearing disorders, such as abnormal speech perception, are frequently reported in individuals with autism. However, the mechanisms underlying these auditory-associated signature deficits in autism remain largely unknown. In this study, we documented significant behavioral impairments in the sound temporal rate discrimination task for rats prenatally exposed to valproic acid (VPA), a well-validated animal model for studying the pathology of autism. In parallel, there was a large-scale degradation in temporal information-processing in their primary auditory cortices (A1) at both levels of spiking outputs and synaptic inputs. Substantially increased spine density of excitatory neurons and decreased numbers of parvalbumin- and somatostatin-labeled inhibitory inter-neurons were also recorded in the A1 after VPA exposure. Given the fact that cortical temporal processing of sound is associated with speech perception in humans, these results in the animal model of VPA exposure provide insight into a possible neurological mechanism underlying auditory and language-related deficits in individuals with autism. |
Persistent Identifier | http://hdl.handle.net/10722/314501 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheng, Y | - |
dc.contributor.author | Tang, B | - |
dc.contributor.author | Zhang, G | - |
dc.contributor.author | An, P | - |
dc.contributor.author | Sun, Y | - |
dc.contributor.author | Gao, M | - |
dc.contributor.author | Zhang, Y | - |
dc.contributor.author | Shan, Y | - |
dc.contributor.author | Zhang, J | - |
dc.contributor.author | Liu, Q | - |
dc.contributor.author | Lai, SWC | - |
dc.contributor.author | de Villers-Sidani, E | - |
dc.contributor.author | Wang, Y | - |
dc.contributor.author | Zhou, X | - |
dc.date.accessioned | 2022-07-22T05:25:43Z | - |
dc.date.available | 2022-07-22T05:25:43Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Neuropharmacology, 2022, v. 209, p. 109000 | - |
dc.identifier.uri | http://hdl.handle.net/10722/314501 | - |
dc.description.abstract | Hearing disorders, such as abnormal speech perception, are frequently reported in individuals with autism. However, the mechanisms underlying these auditory-associated signature deficits in autism remain largely unknown. In this study, we documented significant behavioral impairments in the sound temporal rate discrimination task for rats prenatally exposed to valproic acid (VPA), a well-validated animal model for studying the pathology of autism. In parallel, there was a large-scale degradation in temporal information-processing in their primary auditory cortices (A1) at both levels of spiking outputs and synaptic inputs. Substantially increased spine density of excitatory neurons and decreased numbers of parvalbumin- and somatostatin-labeled inhibitory inter-neurons were also recorded in the A1 after VPA exposure. Given the fact that cortical temporal processing of sound is associated with speech perception in humans, these results in the animal model of VPA exposure provide insight into a possible neurological mechanism underlying auditory and language-related deficits in individuals with autism. | - |
dc.language | eng | - |
dc.relation.ispartof | Neuropharmacology | - |
dc.title | Degraded cortical temporal processing in the valproic acid-induced rat model of autism | - |
dc.type | Article | - |
dc.identifier.email | Lai, SWC: coraswl@hku.hk | - |
dc.identifier.authority | Lai, SWC=rp01895 | - |
dc.identifier.doi | 10.1016/j.neuropharm.2022.109000 | - |
dc.identifier.hkuros | 334430 | - |
dc.identifier.volume | 209 | - |
dc.identifier.spage | 109000 | - |
dc.identifier.epage | 109000 | - |
dc.identifier.isi | WOS:000786647700002 | - |